How should persistent low mood be managed in a patient taking bupropion (Wellbutrin) 300 mg daily, trazodone 50 mg nightly, and L‑methylfolate (Deplin)?

Management of Persistent Low Mood on Current Regimen

You should modify this patient's treatment regimen now, as they have failed to achieve adequate response after what appears to be an adequate trial of bupropion 300 mg daily. The American College of Physicians strongly recommends modifying treatment if patients do not have an adequate response to pharmacotherapy within 6 to 8 weeks of initiation 1.

Immediate Assessment Steps

Before changing therapy, verify:

• Duration on current dose: Has the patient been on bupropion 300 mg for at least 6-8 weeks?
• Medication adherence: Is the patient actually taking medications as prescribed?
• Trazodone role: The 50 mg dose is subtherapeutic for depression (used primarily for sleep here) 2
• Deplin efficacy: While L-methylfolate at 15 mg/day shows benefit as SSRI augmentation 3, 4, evidence for augmenting bupropion specifically is limited

Treatment Modification Options

Option 1: Switch to a Different Second-Generation Antidepressant (Preferred Initial Strategy)

Switch from bupropion to an SSRI or SNRI (sertraline, escitalopram, venlafaxine, or duloxetine). The evidence shows no significant difference in efficacy when switching between second-generation antidepressants 5, 6. Key considerations:

• No single agent is superior for second-line treatment 1
• Choose based on:
  • Side effect profile: If sexual dysfunction is a concern, bupropion had lower rates than SSRIs 1, but the patient is already on it without response
  • Comorbid symptoms: If anxiety is prominent, SSRIs/SNRIs may be preferable 1
  • Cost and patient preference 1

Practical approach: Start sertraline 50 mg daily, titrate to 150-200 mg over 2-4 weeks, or escitalopram 10 mg daily, titrate to 20 mg. Continue Deplin 15 mg as augmentation since it enhances SSRI/SNRI response 3, 4.

Option 2: Augment Current Bupropion

If there has been partial response to bupropion (not complete non-response):

Add an SSRI to bupropion (combination therapy). Evidence shows:

• Augmenting with another second-generation antidepressant is a valid strategy 5
• Bupropion + SSRI addresses different neurotransmitter systems (dopamine/norepinephrine + serotonin)
• Start sertraline 50 mg or escitalopram 10 mg while continuing bupropion 300 mg

Alternative augmentation: Add buspirone 15-30 mg twice daily, though evidence shows similar efficacy to bupropion augmentation 5

Option 3: Add Cognitive Behavioral Therapy

Strongly consider adding CBT regardless of medication changes. Evidence shows:

• CBT combined with antidepressants may be superior to medication alone 5
• CBT has similar efficacy to switching antidepressants 5, 6
• No increased discontinuation rates compared to medication 5

Monitoring Plan

Reassess within 1-2 weeks of any medication change 1:

• Monitor for worsening depression, suicidal ideation (highest risk in first 1-2 months) 1, 7
• Watch for agitation, irritability, unusual behavior changes 1, 7
• Assess for medication-specific side effects

Full response assessment at 6-8 weeks of new regimen 1

Critical Pitfalls to Avoid

1. Don't continue ineffective treatment indefinitely: Response rates to initial antidepressant therapy are only ~50% 1. Multiple trials may be needed.

2. Don't assume trazodone 50 mg is treating depression: This dose is subtherapeutic for depression and primarily addresses sleep 2. If sleep is the only benefit, consider maintaining it while changing the primary antidepressant.

3. Don't overlook non-pharmacologic interventions: The evidence does not justify medication-only approaches when CBT is available 5, 6.

4. Don't increase bupropion above 300 mg daily: This is the maximum approved dose for depression 7. Higher doses increase seizure risk without proven additional benefit 7.

5. Monitor for bupropion-related anxiety: While bupropion can reduce anxiety in some patients 8, its stimulating properties can worsen anxiety, particularly at 300 mg 8. If anxiety is prominent, switching to an SSRI/SNRI is preferable.

Duration of Future Treatment

Once adequate response is achieved, continue treatment for 4-9 months minimum 1. If this is a second or subsequent depressive episode, consider longer-term maintenance therapy 1.